Providing High Value Cost Conscious Care: Introduction to Health Care Value Bindu Swaroop, MD Department of Medicine University of California, Irvine.

Slides:



Advertisements
Similar presentations
Implementing the Stroke Palliative Approach Pathway
Advertisements

Introduction to Health Care Value Providing High-Value Cost-Conscious Care: | Presentation #1 0f 10.
Controversies in the management of Pulmonary Embolism
VTE Toolkit Chapter Five Venous Disease Coalition
ACRIN PA 4005: Multicenter Randomized Controlled Study of a Rapid ‘Rule-out’ Strategy Using CT Coronary Angiogram Versus Traditional Care for Low-Risk.
Good Morning and Welcome Applicants!
Tony Tiemesmann Diagnostic Radiology Bloemfontein Hospital Complex.
P ULMONARY THROMBOEMBOLISM SPECIFIC SITUATIONS Dr.E.Shabani.
The PERC Rule. The paper Kline et al Journal of Thrombosis and Haemostasis 2008 Prospective Multicenter Evaluation of the Pulmonary Embolism Rule Out.
+ Deep Vein Thrombosis Common, Preventable, and potentially Fatal.
Venous Thromboembolism
WA ACEP November Disclaimers Introduction – Choosing Wisely Campaign II 2014 ACEP Recommendations – Avoid: CT scan of the head for asymptomatic.
Copyright © 2013 by Mosby, an imprint of Elsevier Inc. Importance of Health Assessment DSN Kevin Dobi, MS, APRN.
Below the Knee DVT and Pregnancy Related Thrombosis Robert Lampman, MD Morning Report July 2009.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
D-dimer in the Diagnosis of Pulmonary Embolism Cheryl Pollock PGY-3.
DVT: Symptoms and work-up Sean Stoneking. DVT Epidemilogy Approximately 600,0000 new cases of DVT each year 50% in hospitalized patients or nursing home.
What is it? A deep vein thrombosis is a condition where the blood clots in a distal, deep vein A blood clot is considered a thrombosis as long as it is.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Project: Ghana Emergency Medicine Collaborative Document Title: Pulmonary Embolism Part 2 (2012) Author(s): Rockefeller A. Oteng, M.D., University of Michigan.
Syncope & serial troponins don’t mix Cost Containment Project June 2015 Alex Raufi PGY2.
Prospective evaluation of Innovance D-dimer in the exclusion of venous thromboembolism [VTE]. Robert Gosselin, CLS Department of Clinical Pathology and.
Ambulatory Emergency Care A Generalist’s View
The potential impact of adherence to a guideline on the utilization of head CT scans in traumatic head injury patients. Frederick K. Korley M.D.
Case Report Pneumology Dr. David Tran A&E, FVHospital Medical meeting September 28 th, 2011.
Evidence Based Medicine Workshop Diagnosis March 18, 2010.
 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.
What the College is doing for you & High Value Care Robert H. Lohr, MD, FACP Board of Regents American College of Physicians.
71-year old male Admitted with worsening shortness of breath PMHx: Severe COPD, A.Fib, CHF/ischemic, PE On long term anticoagulation with Pradaxa 150.
Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.
1. Statistics Objectives: 1.Try to differentiate between the P value and alpha value 2.When to perform a test 3.Limitations of different tests and how.
Appropriateness of PE workup at UCI based on Well’s Criteria Amy Ni, MD Cost Consciousness Project: March 2015.
PE Clinical Evaluation. Presenting Complaint Most common presenting complaint: dyspnoea Chest pain Syncope Cough Leg pain.
Prof. Mona Mansour Professor of Pulmonary Medicine Ain Shams University.
Excluding the Diagnosis of Pulmonary Embolism: Is There a Magic Ball? COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
Diagnostic Test Characteristics: What does this result mean
Validation and Refinement of a Prediction Rule to Identify Children at Low Risk for Acute Appendicitis Kharbanda AB, Dudley NC, Bajaj L, et al; Pediatric.
PULMONARY EMBOLISM BY Dr. Hayam Hebah Associate professor of internal medicine AL-Maarefa College.
Eliminating Health Care Waste and Over-ordering of Tests Fellowship HVC Curriculum Presentation 1 of 7.
Diagnosis of Deep Vein Thrombosis Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention of Thrombosis, 9th.
Pulmonary Embolism Pulmonary Embolism Ma hong Depart. of Medical Imaging, Xuzhou Medical College.
Pulmonary Embolism and the Role of Echocardiograms in Management
Ten Minute Training March 21, 2012 Alerting. 2 |2 | DynaMed is an evidence-based clinical reference tool designed primarily for use by health care professionals.
High Value Quality Improvement Presentation 6 of 6.
Venous Thromboembolic Disease: The Role of Novel Anticoagulants Grant M. Greenberg MD, MA, MHSA.
Asad Mehdi, MD. Outline A Diagnostic Approach to Pulmonary Embolism Clinical Presentation Risk Stratification Wells Criteria Geneva Rule PIOPED Approach.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Pulmonary Embolism in Patients with Unexplained Exacerbation of COPD: Prevalence and Risk Factors Isabelle Tillie-Leblond, MD, PhD; Charles-Hugo Marquette,
Outpatient DVT assessment & treatment Daniel Gilada.
Eliminating healthcare waste and over-ordering of tests Presentation 1 of 6.
An Introduction to: rscan.org. What is R-SCAN? 2 A clinical practice improvement activity for radiologists and referring practitioners to:  Improve imaging.
High Value Quality Improvement Fellowship HVC Curriculum Presentation 7 of 7.
Diagnosis Recitation. The Dilemma At the conclusion of my “diagnosis” presentation during the recent IAPA meeting, a gentleman from the audience asked.
Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients Thrombosis Research (2008)
Pulmonary Embolism Presentation to Diagnosis
E-QUAL Avoidable Imaging Kick Off
Background Methods Results Discussion Conclusion
the proximal femoral fracture patients
Choosing Wisely : Radiology Perspective
. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Comparative Efficiency of Exercise Stress Testing With.
Evidence Based and Cost Effective Guideline for DVT Triage
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
Measuring Efficiency HSCRC Performance Measurement Workgroup
Providing High Value Cost Conscious Care:
Cost-Effectiveness of Strategies for Diagnosing Pulmonary Embolism Among Emergency Department Patients Presenting With Undifferentiated Symptoms  Ram.
Venous Thromboembolism (VTE)
Measuring Efficiency HSCRC Performance Measurement Workgroup
CTA chest use in ED to fish for PEs
Calculate Well’s score for PE (BOX1)
Presentation transcript:

Providing High Value Cost Conscious Care: Introduction to Health Care Value Bindu Swaroop, MD Department of Medicine University of California, Irvine

Learning Objectives Understand some of the current problems with health care spending Define high value, cost conscious care Introduce the five step model for delivering high value, cost conscious care Articulate strategies for bringing high value care into daily practice

What is the Problem? We spend too much on healthcare- $2.6 trillion in 2010, representing 17.6% of the GDP IOM report in 2009: ▫ About 30 cents of every health care dollar is wasted ▫ $750 billion in inefficient health care spending ▫ "Left unchanged, health care will continue to underperform, cause unnecessary harm, and strain national, state, and family budgets"

Wasted Healthcare In 2009: Unnecessary services $210 B Inefficient services $130 B Excess administrative costs $190 B Prices too high $105 B Missed prevention opportunities $ 55 B Fraud $75 B

Wasted Healthcare In 2009: Unnecessary services $210 B Inefficient services $130 B Excess administrative costs $190 B Prices too high $105 B Missed prevention opportunities $ 55 B Fraud $75 B

Ordering more services 3 … Two areas of greatest expenditures and most rapid growth: imaging and tests Tests Imaging

.

What is High Value, Cost Conscious Care? Providing the best possible care to our patients and Simultaneously reducing unnecessary costs to the healthcare system

Copyright © The American College of Physicians. All rights reserved.

Value, Cost and Health Care Cost ≠ Value Cost ≠ Cost of Test Cost includes cost of test and downstream costs, benefits and harms High-cost interventions may provide good value because they are highly beneficial Low-cost interventions may have little or no value if they provide little benefit or increase downstream costs

Steps Toward High Value, Cost Conscious Care Five-Step Framework: High-Value, Cost-Conscious Care Step 1 Understand the benefits, harms, and relative costs of the interventions that you are considering Step 2 Decrease or eliminate the use of interventions that provide no benefit and/or may be harmful Step 3 Choose interventions and care settings that maximize benefits, minimize harms, and reduce costs (using comparative-effectiveness and cost-effectiveness data) Step 4 Customize a care plan with the patient that incorporates their values and addresses their concerns Step 5 Identify system-level opportunities to improve outcomes, minimize harms, and reduce health care waste

Case Presentation 70 y/o female POD#3 from laparoscopic cholecystectomy Patient recovering well with plan for discharge While ambulating became acutely SOB, tachycardic and hypotensive Complained of right shoulder and chest pain associated with diaphoresis

Step 1: Benefits, Harms, Costs What is your work-up? What factors lead us to make these orders or recommendations? How much does this cost?

Benefits, Harms, Costs TestBenefitHarmCosts CT Angio TTE EKG D-dimer BNP Troponin (serial) ABG LE U/S Doppler Hypercoagulable work up

Benefits, Harms, Costs TestBenefitHarmCosts CT Angio Best sensitivity for identifying PE TTE Assess RV strain EKG Identify arrythmia, non-invasive D-dimer Easy to obtain, helpful in ruling out PE if negative BNP Troponin (serial) ABG LE U/S Dopplerno contrast, non- invasive Hypercoagulable work up

Benefits, Harm, Costs TestBenefitHarmCosts CT Angio Best sensitivity for identifying PE Contrast, radiation, incidental findings TTE Assess RV strain Low specificity EKG Identify arrythmia, non-invasive D-dimer Easy to obtain, helpful in ruling out PE if negative Low specificity BNP Troponin (serial) Repeated phlebotomy ABGArterial Stick LE U/S Dopplerno contrast, non- invasive Hypercoagulable work up Low yield in patient with clear risk factor for PE

Benefits, Harms, Costs TestBenefitHarmCosts CT AngioBest sensitivity for identifying PE Contrast, radiation, incidental findings $ TTE$ EKG Identify arrythmia, non-invasive $79.18 D-dimer Easy to obtain, helpful in ruling out PE if negative Low specificity$65.88 BNP$18.75 Troponin (serial)Repeated phlebotomy $26.01 (x 1) ABGArterial Stick$35.94 LE U/S Dopplerno contrast, non- invasive $ Hypercoagulable work up Low yield in patient with clear risk factor for PE $79.18

Step 2: Decrease or eliminate care that provides no benefit and/or may be harmful Which tests had the potential to change management? -CT Angio -D-dimer -Fibrinogen -BNP -Serial Troponin -Hypercoagulable panel -TTE -LE Ultrasound -ABG

Step 2: Decrease or eliminate care that provides no benefit and/or may be harmful Which tests had the potential to change management? -CT Angio -D-dimer -Fibrinogen -BNP -Serial Troponin -Hypercoagulable panel -TTE -LE Ultrasound -ABG

Step 2: Decrease or eliminate care that provides no benefit and/or may be harmful Which tests had the potential to change management? -CT Angio: $294 -D-dimer -Fibrinogen -BNP -Serial Troponin -Hypercoagulable panel -TTE -LE Ultrasound -ABG Total Cost: $871.85

Step 2: Decrease or eliminate care that provides no benefit and/or may be harmful

Step 3: Choose interventions and care settings that maximize benefits, minimize harms, and reduce costs Use comparative-effectiveness and cost- effectiveness data In this case: Well’s or Geneva Score to determine pre test probability Mini Lectures | Residency Program | Residency Program | Department of Medicine | School of Medicine | University of California, Irvine

Wells’ Score Clinical symptoms of DVT (leg swelling, pain with palpation) 3.0 Other diagnosis less likely than pulmonary embolism 3.0 Heart rate > Immobilization (≥3 days) or surgery in the previous four weeks 1.5 Previous DVT/PE1.5 Hemoptysis1.0 Malignancy1.0 Traditional clinical probability assessment (Wells criteria) High>6.0 Moderate2.0 to 6.0 Low<2.0 Simplified clinical probability assessment (Modified Wells criteria) PE likely>4.0 PE unlikely≤4.0

Simplified Geneva Score VariableScore Age >651 Previous DVT or PE1 Surgery or fracture within 1 month1 Active malignancy1 Unilateral lower limb pain1 Hemoptysis1 Pain on deep vein palpation of lower limb and unilateral edema 1 Heart rate 75 to 94 bpm1 Heart rate greater than 94 bpm2 Score of less than 2 is low probablility for PE, score of less than 2 plus a negative D-dimer results in a likelihood of PE of 3%

Diagnostic Algorithm

Effective Use of CTA in Setting of Suspected Pulmonary Embolism By Sasan Sani MD.

Methods 40 CTA exams Performed 3/10-3/25 were analyzed retrospectively 55% of these studies were noted to have “PE Rule Out” as their indication Laboratory and imaging results were reviewed on Quest Documentation (H&Ps, progress notes, DC summaries, consultations) were also reviewed on Quest Well’s Score and Geneva Score were calculated according to the collected data Data limited by information provided in notes

Departments

Wells’ Score

Results Only 2 (9%) out of the 22 CT angiograms performed showed evidence of PE 80% of patients had a Well’s score in the range of “Unlikely PE” (<4) 50% of these patients had a score of <2 (low probability) D-dimer was checked for only two out of all the patients ▫one positive D-dimer in setting of PE ▫one negative in the setting of a negative CTA Lower extremity ultrasound was also performed for 4 patients (18%) ▫Only one patient had evidence of DVT, and this patient was diagnosed with PE as well

Discussion Previous studies performed have shown similar results In a cross-sectional study reviewing 589 pulmonary CTA ordered in the emergency department PE was found in 9% A total of 33% had findings that supported alternative diagnoses 24% had incidental findings that required diagnostic follow up ▫13% new pulmonary nodule ▫9% new adenopathy The conclusion was that CTA was more than twice as likely to find an incidental pulmonary nodule or adenopathy than a PE

Conclusion Patients should be risk stratified appropriately and diagnostic algorithms should be used prior to ordering diagnostic tests CT angiograms should be utilized in high probability patients or those with suspected PE and a positive D-dimer result

Step 4: Customize a care plan with the patient that incorporates their values and addresses their concerns “And no one thought to get a potassium level?”

Step 4: Customize a care plan with the patient that incorporates their values and addresses their concerns “It is more important to know what sort of person has a disease than to know what sort of disease a person has.” -Hippocrates ( B.C.) “And no one thought to get a potassium level?”

Step 4: Customize a care plan with the patient that incorporates their values and addresses their concerns “It is more important to know what sort of person has a disease than to know what sort of disease a person has.” -Hippocrates ( B.C.) Patient Centered Care: “Providing care that is respectful of and responsive to individual patient preferences, needs, values, and ensuring that patient values guide all clinical decisions” (IOM 2001) “And no one thought to get a potassium level?”

Quiz: What is the patient charged? One bag of normal saline given IV: Actual bill: $158.55

Quiz: What does is the patient charged? A comprehensive metabolic panel: Actual bill: $1,212.00

Quiz: What is the patient charged? One set of blood cultures: Actual bill: $510 (remember, we usually order 2 sets)

Quiz: What is the patient charged? Electrocardiogram: Actual bill: $706 (just for the tracing, not including interpretation by a physician)

What is the patient charged? Troponin (x 1): Actual bill: $402 (remember, we usually order x 3)

Quiz: What is the patient charged? CT Head w/o contrast: Actual bill: $2930

ED Bill Community hospital in Southern California Patient fell, seen in ED for evaluation Clinically stable Discharged from ED Total cost billed to patient (not including physician fees): $10,

Disclaimer Cost of test and charge to patient is complex and involves many factors, and is not just monetary Clinical reasoning and individualized care are very important Cost-conscious care is not about discouraging appropriate care, nor denying beneficial services

Steps Toward High Value, Cost Conscious Care Five-Step Framework: High-Value, Cost-Conscious Care Step 1 Understand the benefits, harms, and relative costs of the interventions that you are considering Step 2 Decrease or eliminate the use of interventions that provide no benefit and/or may be harmful Step 3 Choose interventions and care settings that maximize benefits, minimize harms, and reduce costs (using comparative-effectiveness and cost-effectiveness data) Step 4 Customize a care plan with the patient that incorporates their values and addresses their concerns Step 5 Identify system-level opportunities to improve outcomes, minimize harms, and reduce health care waste

Summary START: Using validated clinical tools and follow diagnostic algorithms to avoid overuse of tests Asking yourself before you order the test if the results will change what you do for the patient STOP: routinely obtaining studies if results will not alter your management